{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:50:04Z","timestamp":1794019804389,"version":"4.8.0"},"reference-count":208,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomaterials"],"abstract":"<jats:p>The lack of effective treatments for neurodegenerative diseases (NDs) is an important current concern. Lipid nanoparticles can deliver innovative combinations of active molecules to target the various mechanisms of neurodegeneration. A significant challenge in delivering drugs to the brain for ND treatment is associated with the blood\u2013brain barrier, which limits the effectiveness of conventional drug administration. Current strategies utilizing lipid nanoparticles and cell-penetrating peptides, characterized by various uptake mechanisms, have the potential to extend the residence time and bioavailability of encapsulated drugs. Additionally, bioactive molecules with neurotropic or neuroprotective properties can be delivered to potentially mediate the ND targeting pathways, e.g., neurotrophin deficiency, impaired lipid metabolism, mitochondrial dysfunction, endoplasmic reticulum stress, accumulation of misfolded proteins or peptide fragments, toxic protein aggregates, oxidative stress damage, and neuroinflammation. This review discusses recent advancements in lipid nanoparticles and CPPs in view of the integration of these two approaches into nanomedicine development and dual-targeted nanoparticulate systems for brain delivery in neurodegenerative disorders.<\/jats:p>","DOI":"10.3390\/nano13233004","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T03:45:18Z","timestamp":1700711118000},"page":"3004","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders"],"prefix":"10.3390","volume":"13","author":[{"given":"Yu","family":"Wu","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0285-0637","authenticated-orcid":false,"given":"Angelina","family":"Angelova","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s Disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.2147\/IJN.S30919","article-title":"Neurological Disorders and Therapeutics Targeted to Surmount the Blood\u2013Brain Barrier","volume":"7","author":"Kanwar","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Daneman, R., and Prat, A. (2015). The Blood\u2013Brain Barrier. Cold Spring Harb. Perspect. Biol., 7.","DOI":"10.1101\/cshperspect.a020412"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-8946-1_1","article-title":"An Overview of the Blood-Brain Barrier","volume":"142","author":"Barichello","year":"2019","journal-title":"Blood-Brain Barrier"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrd2368","article-title":"Modelling of the Blood\u2013Brain Barrier in Drug Discovery and Development","volume":"6","author":"Cecchelli","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17523","DOI":"10.1038\/s41598-018-35976-2","article-title":"Brain-Specific Ultrastructure of Capillary Endothelial Glycocalyx and Its Possible Contribution for Blood Brain Barrier","volume":"8","author":"Ando","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wong, K., Riaz, M., Xie, Y., Zhang, X., Liu, Q., Chen, H., Bian, Z., Chen, X., Lu, A., and Yang, Z. (2019). Review of Current Strategies for Delivering Alzheimer\u2019s Disease Drugs across the Blood-Brain Barrier. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020381"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The Role of Brain Vasculature in Neurodegenerative Disorders","volume":"21","author":"Sweeney","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1602\/neurorx.2.1.44","article-title":"Development of Neuropeptide Drugs That Cross the Blood-Brain Barrier","volume":"2","author":"Egleton","year":"2005","journal-title":"NeuroRx"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","article-title":"Delivery of Peptide and Protein Drugs over the Blood\u2013Brain Barrier","volume":"87","author":"Brasnjevic","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1021\/acsnano.5b05341","article-title":"Penetrating the Blood\u2013Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles","volume":"9","author":"Ali","year":"2015","journal-title":"ACS Nano"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/edrv-7-3-314","article-title":"Receptor-Mediated Peptide Transport through the Blood-Brain Barrier","volume":"7","author":"Pardridge","year":"1986","journal-title":"Endocr. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1073\/pnas.88.11.4771","article-title":"Anti-Transferrin Receptor Antibody and Antibody-Drug Conjugates Cross the Blood-Brain Barrier","volume":"88","author":"Friden","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apha.12250","article-title":"The Neurovascular Unit\u2014Concept Review","volume":"210","author":"Muoio","year":"2014","journal-title":"Acta Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fnins.2020.00334","article-title":"Neurovascular Unit Dysfunction and Neurodegenerative Disorders","volume":"14","author":"Yu","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.2147\/IJN.S210876","article-title":"Recent Expansions of Novel Strategies towards the Drug Targeting into the Brain","volume":"14","author":"Alexander","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.drudis.2013.07.010","article-title":"Neurotrophin Delivery Using Nanotechnology","volume":"18","author":"Angelova","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejpb.2022.11.003","article-title":"Current Approaches to Facilitate Improved Drug Delivery to the Central Nervous System","volume":"181","author":"Markiewicz","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ajps.2022.05.002","article-title":"Overcoming the Cellular Barriers and beyond: Recent Progress on Cell Penetrating Peptide Modified Nanomedicine in Combating Physiological and Pathological Barriers","volume":"17","author":"Liu","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"19141","DOI":"10.1073\/pnas.2002016117","article-title":"Targeting Nanoparticles to the Brain by Exploiting the Blood\u2013Brain Barrier Impermeability to Selectively Label the Brain Endothelium","volume":"117","author":"Liu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"eabm8011","DOI":"10.1126\/sciadv.abm8011","article-title":"Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy","volume":"8","author":"Zou","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1038\/s41598-017-11220-1","article-title":"Targeting Transferrin Receptors at the Blood-Brain Barrier Improves the Uptake of Immunoliposomes and Subsequent Cargo Transport into the Brain Parenchyma","volume":"7","author":"Johnsen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1039\/D0BM01755H","article-title":"Cell-Penetrating Peptides (CPPs): An Overview of Applications for Improving the Potential of Nanotherapeutics","volume":"9","author":"Desale","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Langel, \u00dc. (2019). CPP, Cell-Penetrating Peptides, Springer.","DOI":"10.1007\/978-981-13-8747-0"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Neves-Coelho, S., Eleut\u00e9rio, R.P., Enguita, F.J., Neves, V., and Castanho, M.A.R.B. (2017). A New Noncanonical Anionic Peptide That Translocates a Cellular Blood\u2013Brain Barrier Model. Molecules, 22.","DOI":"10.3390\/molecules22101753"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Keighron, C.N., Avazzadeh, S., Goljanek-Whysall, K., McDonagh, B., Howard, L., Ritter, T., and Quinlan, L.R. (2023). Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson\u2019s and Alzheimer\u2019s Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030728"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.biopha.2018.09.097","article-title":"Cell Penetrating Peptides: A Concise Review with Emphasis on Biomedical Applications","volume":"108","author":"Derakhshankhah","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1600-0854.2007.00572.x","article-title":"A Comprehensive Model for the Cellular Uptake of Cationic Cell-Penetrating Peptides","volume":"8","author":"Duchardt","year":"2007","journal-title":"Traffic"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.addr.2004.10.009","article-title":"Membrane-Permeable Arginine-Rich Peptides and the Translocation Mechanisms","volume":"57","author":"Futaki","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s10194-018-0861-3","article-title":"Transport of the Pituitary Adenylate Cyclase-Activating Polypeptide across the Blood-Brain Barrier: Implications for Migraine","volume":"19","author":"Amin","year":"2018","journal-title":"J. Headache Pain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0167-0115(92)90621-Z","article-title":"Pituitary Adenylate Cyclase Activating Polypeptide (PACAP): Discovery and Current Status of Research","volume":"37","author":"Arimura","year":"1992","journal-title":"Regul. Pept."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12640-009-9091-4","article-title":"Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice","volume":"17","author":"Deguil","year":"2010","journal-title":"Neurotox. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuropharm.2015.05.014","article-title":"Characterizations of a Synthetic Pituitary Adenylate Cyclase-Activating Polypeptide Analog Displaying Potent Neuroprotective Activity and Reduced in Vivo Cardiovascular Side Effects in a Parkinson\u2019s Disease Model","volume":"108","author":"Lamine","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12031-016-0731-x","article-title":"Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Involved in Adult Mouse Hippocampal Neurogenesis After Stroke","volume":"59","author":"Matsumoto","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12031-014-0309-4","article-title":"PACAP38 Suppresses Cortical Damage in Mice with Traumatic Brain Injury by Enhancing Antioxidant Activity","volume":"54","author":"Miyamoto","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fncel.2020.00221","article-title":"Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases","volume":"14","author":"Vaudry","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-022-02639-z","article-title":"The neuropeptide PACAP alleviates T. gondii infection-induced neuroinflammation and neuronal impairment","volume":"19","author":"Figueiredo","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Rivnyak, A., Kiss, P., Tamas, A., Balogh, D., and Reglodi, D. (2018). Review on PACAP-Induced Transcriptomic and Proteomic Changes in Neuronal Development and Repair. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041020"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1073\/pnas.0600375103","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6","volume":"103","author":"Ohtaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fendo.2019.00227","article-title":"Expression Patterns of PACAP and PAC1R Genes and Anorexigenic Action of PACAP1 and PACAP2 in Zebrafish","volume":"10","author":"Nakamachi","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"585082","DOI":"10.3389\/fendo.2020.585082","article-title":"Intranasal Administration of PACAP Is an Efficient Delivery Route to Reduce Infarct Volume and Promote Functional Recovery after Transient and Permanent Middle Cerebral Artery Occlusion","volume":"11","author":"Cherait","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1002\/anie.201411408","article-title":"Applying the Retro-Enantio Approach To Obtain a Peptide Capable of Overcoming the Blood-Brain Barrier","volume":"54","author":"Prades","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/ange.201411226","article-title":"A D-Peptide Ligand of Nicotine Acetylcholine Receptors for Brain-Targeted Drug Delivery","volume":"127","author":"Wei","year":"2015","journal-title":"Angew. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1078-0432.CCR-12-2481","article-title":"Phase I Study of GRN1005 in Recurrent Malignant Glioma","volume":"19","author":"Drappatz","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Guo, P., Ma, Z., Lu, P., Kebebe, D., and Liu, Z. (2021). Combination of Cell-Penetrating Peptides with Nanomaterials for the Potential Therapeutics of Central Nervous System Disorders: A Review. J. Nanobiotechnol., 19.","DOI":"10.1186\/s12951-021-01002-3"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2191891","DOI":"10.1080\/10717544.2023.2191891","article-title":"Investigation of Enhanced Intracellular Delivery of Nanomaterials Modified with Novel Cell-Penetrating Zwitterionic Peptide-Lipid Derivatives","volume":"30","author":"Sugimoto","year":"2023","journal-title":"Drug Deliv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"13121","DOI":"10.1021\/acsnano.2c08275","article-title":"Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain","volume":"17","author":"Nong","year":"2023","journal-title":"ACS Nano"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Gajbhiye, K.R., Pawar, A., Mahadik, K.R., and Gajbhiye, V. (2020). PEGylated Nanocarriers: A Promising Tool for Targeted Delivery to the Brain. Colloids Surf. B Biointerfaces, 187.","DOI":"10.1016\/j.colsurfb.2019.110770"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1248\/bpb.b18-00683","article-title":"Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke","volume":"42","author":"Fukuta","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"198114","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 Vaccine: A Comprehensive Status Report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"114861","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid Nanoparticle-Mediated Drug Delivery to the Brain","volume":"197","author":"Khare","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Angelova, A., Angelov, B., Drechsler, M., Bizien, T., Gorshkova, Y.E., and Deng, Y. (2021). Plasmalogen-Based Liquid Crystalline Multiphase Structures Involving Docosapentaenoyl Derivatives Inspired by Biological Cubic Membranes. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.617984"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Shabani, L., Abbasi, M., Azarnew, Z., Amani, A.M., and Vaez, A. (2023). Neuro-nanotechnology: Diagnostic and therapeutic nano-based strategies in applied neuroscience. BioMed. Eng. OnLine, 22.","DOI":"10.1186\/s12938-022-01062-y"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1021\/acsnano.3c02268","article-title":"Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease","volume":"17","author":"Palanki","year":"2023","journal-title":"ACS Nano"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molmed.2023.02.004","article-title":"Brain Gene Therapy with Trojan Horse Lipid Nanoparticles","volume":"29","author":"Pardridge","year":"2023","journal-title":"Trends Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Torres, J., Costa, I., Peixoto, A.F., Silva, R., Sousa Lobo, J.M., and Silva, A.C. (2023). Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases. Pharmaceuticals, 16.","DOI":"10.3390\/ph16020311"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Akanchise, T., and Angelova, A. (2023). Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome. Antioxidants, 12.","DOI":"10.3390\/antiox12020393"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/17425247.2018.1471058","article-title":"Recent Advancements in the Field of Nanotechnology for the Delivery of Anti-Alzheimer Drug in the Brain Region","volume":"15","author":"Agrawal","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_60","unstructured":"Rakotoarisoa, M., and Angelova, A. (2020). The Road from Nanomedicine to Precision Medicine, Jenny Stanford Publishing."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pneurobio.2017.07.003","article-title":"Nanomaterial Applications for Neurological Diseases and Central Nervous System Injury","volume":"157","author":"Huang","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/cnma.201900468","article-title":"Pep-Lipid Cubosomes and Vesicles Compartmentalized by Micelles from Self-Assembly of Multiple Neuroprotective Building Blocks Including a Large Peptide Hormone PACAP-DHA","volume":"5","author":"Angelova","year":"2019","journal-title":"ChemNanoMat"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4103\/1673-5374.208546","article-title":"Dual and Multi-Drug Delivery Nanoparticles towards Neuronal Survival and Synaptic Repair","volume":"12","author":"Angelova","year":"2017","journal-title":"Neural Regen. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2020.01.039","article-title":"A Dual-Ligand Fusion Peptide Improves the Brain-Neuron Targeting of Nanocarriers in Alzheimer\u2019s Disease Mice","volume":"320","author":"Guo","year":"2020","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijbiomac.2022.03.203","article-title":"Functionalized Nanoparticles for Brain Targeted BDNF Gene Therapy to Rescue Alzheimer\u2019s Disease Pathology in Transgenic Mouse Model","volume":"208","author":"Arora","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Silva, S., Marto, J., Gon\u00e7alves, L.M., Duarte, D., Soares, O.S.G.P., Vasques-N\u00f3voa, F., Almeida, A.J., and Vale, N. (2022). New Peptide Functionalized Nanostructured Lipid Carriers with CNS Drugs and Evaluation Anti-Proliferative Activity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137109"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.119.264127","article-title":"Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain","volume":"374","author":"Lakkadwala","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1007\/s11064-020-03122-y","article-title":"Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects after Demyelination In Vitro","volume":"45","author":"Fressinaud","year":"2020","journal-title":"Neurochem. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.reth.2022.12.007","article-title":"Surface Modulation of Extracellular Vesicles with Cell-Penetrating Peptide-Conjugated Lipids for Improvement of Intracellular Delivery to Endothelial Cells","volume":"22","author":"Huang","year":"2023","journal-title":"Regen. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1039\/D0TB01940B","article-title":"Cell-Penetrating Peptide-Conjugated Lipid\/Polymer Hybrid Nanovesicles for Endoplasmic Reticulum-Targeting Intracellular Delivery","volume":"9","author":"Kim","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/01.CIR.0000163542.48611.A2","article-title":"Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor\u2013Related Protein-Mediated Transcytosis","volume":"111","author":"Benchenane","year":"2005","journal-title":"Circulation"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1096\/fj.201600827R","article-title":"Use of LDL Receptor\u2014Targeting Peptide Vectors for in Vitro and in Vivo Cargo Transport across the Blood-Brain Barrier","volume":"31","author":"Molino","year":"2017","journal-title":"FASEB J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2015.11.032","article-title":"Revisiting Nanoparticle Technology for Blood\u2013Brain Barrier Transport: Unfolding at the Endothelial Gate Improves the Fate of Transferrin Receptor-Targeted Liposomes","volume":"222","author":"Johnsen","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_74","first-page":"595","article-title":"Lipid-Based Colloidal Carriers for Peptide and Protein Delivery\u2013Liposomes versus Lipid Nanoparticles","volume":"2","author":"Martins","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ghorai, S.M., Deep, A., Magoo, D., Gupta, C., and Gupta, N. (2023). Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood\u2013Brain Barrier (BBB). Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071999"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/acs.molpharmaceut.2c00523","article-title":"Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges","volume":"19","author":"Parrasia","year":"2022","journal-title":"Mol. Pharm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acs.bioconjchem.3c00369","article-title":"Elucidating the Impact of Payload Conjugation on the Cell-Penetrating Efficiency of the Endosomal Escape Peptide dfTAT: Implications for Future Designs for CPP-Based Delivery Systems","volume":"34","author":"Diaz","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1021\/acs.jpcb.0c01618","article-title":"Prediction of Amphiphilic Cell-Penetrating Peptide Building Blocks from Protein-Derived Amino Acid Sequences for Engineering of Drug Delivery Nanoassemblies","volume":"124","author":"Feger","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.ejps.2021.106094","article-title":"Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines","volume":"169","author":"Sadeghian","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/jm040114b","article-title":"Chemical Modification of Paclitaxel (Taxol) Reduces P-Glycoprotein Interactions and Increases Permeation across the Blood\u2212Brain Barrier in Vitro and in Situ","volume":"48","author":"Rice","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","article-title":"Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means","volume":"42","author":"Kroll","year":"1998","journal-title":"Neurosurgery"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gernert, M., and Feja, M. (2020). Bypassing the Blood\u2013Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121134"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Hanson, L.R., and Frey, W.H. (2008). Intranasal Delivery Bypasses the Blood-Brain Barrier to Target Therapeutic Agents to the Central Nervous System and Treat Neurodegenerative Disease. BMC Neurosci., 9.","DOI":"10.1186\/1471-2202-9-S3-S5"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Langel, \u00dc. (2015). Cell-Penetrating Peptides: Methods and Protocols, Methods in Molecular Biology; Springer.","DOI":"10.1007\/978-1-4939-2806-4"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"100014","DOI":"10.1016\/j.xcrp.2020.100014","article-title":"Designed Cell-Penetrating Peptide Inhibitors of Amyloid-Beta Aggregation and Cytotoxicity","volume":"1","author":"Kumar","year":"2020","journal-title":"Cell Rep. Phys. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Borsello, T. (2007). Neuroprotection Methods and Protocols, Humana Press. Methods in Molecular Biology.","DOI":"10.1007\/978-1-59745-504-6"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous Functional Domains of Chemically Synthesized Human Immunodeficiency Virus Tat Trans-Activator Protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biochi.2014.07.022","article-title":"On the Importance of Electrostatic Interactions between Cell Penetrating Peptides and Membranes: A Pathway toward Tumor Cell Selectivity?","volume":"107","author":"Jobin","year":"2014","journal-title":"Biochimie"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2019.07.020","article-title":"Cell-Penetrating Peptide: A Means of Breaking through the Physiological Barriers of Different Tissues and Organs","volume":"309","author":"Xu","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0006-3495(03)74537-8","article-title":"Charge-Dependent Translocation of the Trojan Peptide Penetratin across Lipid Membranes","volume":"85","author":"Binder","year":"2003","journal-title":"Biophys. J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e00334","DOI":"10.1002\/prp2.334","article-title":"Arginine-Rich Membrane-Permeable Peptides Are Seriously Toxic","volume":"5","author":"Li","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/nar\/gkg385","article-title":"Insight into the Mechanism of the Peptide-based Gene Delivery System MPG: Implications for Delivery of siRNA into Mammalian Cells","volume":"31","author":"Simeoni","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1432-1033.2004.04022.x","article-title":"Membrane Interaction and Cellular Internalization of Penetratin Peptides","volume":"271","author":"Christiaens","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/bi501392n","article-title":"Translocation Mechanism(s) of Cell-Penetrating Peptides: Biophysical Studies Using Artificial Membrane Bilayers","volume":"54","author":"Chassaing","year":"2015","journal-title":"Biochemistry"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Kalafatovic, D., and Giralt, E. (2017). Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity. Molecules, 22.","DOI":"10.3390\/molecules22111929"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1016\/j.bmcl.2011.04.138","article-title":"Evaluation of a Cell Penetrating Prenylated Peptide Lacking an Intrinsic Fluorophore via in Situ Click Reaction","volume":"21","author":"Ochocki","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1074\/jbc.R112.355461","article-title":"Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-Protein-Coupled Receptor Drug Development","volume":"287","author":"Kuliopulos","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1021\/jm4011675","article-title":"Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress","volume":"57","author":"Walensky","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1021\/ja000563a","article-title":"An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides","volume":"122","author":"Schafmeister","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1021\/acsabm.1c00601","article-title":"Amyloid-like Self-Assembly of a Hydrophobic Cell-Penetrating Peptide and Its Use as a Carrier for Nucleic Acids","volume":"4","author":"Porosk","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1995285","DOI":"10.1080\/21688370.2021.1995285","article-title":"Biotherapeutic Effect of Cell-Penetrating Peptides against Microbial Agents: A Review","volume":"10","author":"Sadiq","year":"2022","journal-title":"Tissue Barriers"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1021\/acs.biomac.1c00242","article-title":"Non-Covalent Carrier Hydrophobicity as a Universal Predictor of Intracellular Protein Activity","volume":"22","author":"Hango","year":"2021","journal-title":"Biomacromolecules"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gayraud, F., Klu\u00dfmann, M., and Neundorf, I. (2021). Recent Advances and Trends in Chemical CPP\u2013Drug Conjugation Techniques. Molecules, 26.","DOI":"10.3390\/molecules26061591"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/acs.nanolett.6b00020","article-title":"Spontaneous Internalization of Cell Penetrating Peptide-Modified Nanowires into Primary Neurons","volume":"16","author":"Lee","year":"2016","journal-title":"Nano Lett."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Wen, X., Wang, K., Zhao, Z., Zhang, Y., Sun, T., Zhang, F., Wu, J., Fu, Y., Du, Y., and Zhang, L. (2014). Brain-Targeted Delivery of Trans-Activating Transcriptor-Conjugated Magnetic PLGA\/Lipid Nanoparticles. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106652"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/j.biomaterials.2008.08.004","article-title":"TAT-Conjugated Nanoparticles for the CNS Delivery of Anti-HIV Drugs","volume":"29","author":"Rao","year":"2008","journal-title":"Biomaterials"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drudis.2014.09.017","article-title":"Therapeutic Applications of the Cell-Penetrating HIV-1 Tat Peptide","volume":"20","author":"Rizzuti","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/aps.2018.5","article-title":"Discovery and Development of NA-1 for the Treatment of Acute Ischemic Stroke","volume":"39","author":"Ballarin","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"12644","DOI":"10.1002\/ange.201403846","article-title":"Angiopep-Conjugated Electro-Responsive Hydrogel Nanoparticles: Therapeutic Potential for Epilepsy","volume":"126","author":"Ying","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.bbamem.2014.04.025","article-title":"A Proapoptotic Peptide Conjugated to Penetratin Selectively Inhibits Tumor Cell Growth","volume":"1838","author":"Alves","year":"2014","journal-title":"Biochim. Biophys. Acta BBA\u2014Biomembr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/psc.2759","article-title":"Liposomal Doxorubicin Doubly Functionalized with CCK8 and R8 Peptide Sequences for Selective Intracellular Drug Delivery","volume":"21","author":"Ringhieri","year":"2015","journal-title":"J. Pept. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1021\/acsami.6b15831","article-title":"Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB","volume":"9","author":"Chen","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/j.vaccine.2015.05.015","article-title":"MPG-Based Nanoparticle: An Efficient Delivery System for Enhancing the Potency of DNA Vaccine Expressing HPV16E7","volume":"33","author":"Saleh","year":"2015","journal-title":"Vaccine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1074\/jbc.M509813200","article-title":"Mechanism of Uptake of C105Y, a Novel Cell-Penetrating Peptide","volume":"281","author":"Rhee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Cherait, A., Banks, W.A., and Vaudry, D. (2023). The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15082032"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s10194-018-0852-4","article-title":"PACAP and Its Role in Primary Headaches","volume":"19","author":"Edvinsson","year":"2018","journal-title":"J. Headache Pain"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"17932","DOI":"10.1038\/s41598-018-35938-8","article-title":"HAI Peptide and Backbone Analogs\u2014Validation and Enhancement of Biostability and Bioactivity of BBB Shuttles","volume":"8","author":"Prades","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1021\/acschembio.7b00087","article-title":"Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood\u2013Brain Barrier through a Receptor-Free Mechanism","volume":"12","author":"Neves","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3109\/1061186X.2015.1025077","article-title":"Co-Delivery of Doxorubicin and siRNA for Glioma Therapy by a Brain Targeting System: Angiopep-2-Modified Poly(Lactic-Co-Glycolic Acid) Nanoparticles","volume":"23","author":"Wang","year":"2015","journal-title":"J. Drug Target."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10989-014-9433-9","article-title":"Angiopep-2-Mediated Delivery of Human Manganese Superoxide Dismutase in Brain Endothelial Cells and Its Protective Effect Against Oxidative Stress","volume":"21","author":"Eiamphungporn","year":"2015","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biomaterials.2014.10.007","article-title":"Tumor Microenvironment Sensitive Doxorubicin Delivery and Release to Glioma Using Angiopep-2 Decorated Gold Nanoparticles","volume":"37","author":"Ruan","year":"2015","journal-title":"Biomaterials"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41418-018-0116-5","article-title":"A Novel Cell-Penetrating Peptide Protects against Neuron Apoptosis after Cerebral Ischemia by Inhibiting the Nuclear Translocation of Annexin A1","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/acs.bioconjchem.7b00190","article-title":"Enhanced and Prolonged Cell-Penetrating Abilities of Arginine-Rich Peptides by Introducing Cyclic \u03b1,\u03b1-Disubstituted \u03b1-Amino Acids with Stapling","volume":"28","author":"Oba","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Madani, F., Lindberg, S., Langel, \u00dc., Futaki, S., and Gr\u00e4slund, A. (2011). Mechanisms of Cellular Uptake of Cell-Penetrating Peptides. J. Biophys., 2011.","DOI":"10.1155\/2011\/414729"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.addr.2004.10.010","article-title":"Cell-Penetrating Peptides: Mechanism and Kinetics of Cargo Delivery","volume":"57","author":"Zorko","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbamem.2004.09.010","article-title":"On the Mechanism of Non-Endosomial Peptide-Mediated Cellular Delivery of Nucleic Acids","volume":"1667","author":"Deshayes","year":"2004","journal-title":"Biochim. Biophys. Acta BBA\u2014Biomembr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1389203033487306","article-title":"TAT Peptide Internalization: Seeking the Mechanism of Entry","volume":"4","author":"Vives","year":"2003","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"16764","DOI":"10.1021\/bi00051a026","article-title":"Membrane Thinning Caused by Magainin 2","volume":"34","author":"Ludtke","year":"1995","journal-title":"Biochemistry"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"12416","DOI":"10.1021\/bi00164a017","article-title":"Interaction of Antimicrobial Dermaseptin and Its Fluorescently Labeled Analogs with Phospholipid Membranes","volume":"31","author":"Pouny","year":"1992","journal-title":"Biochemistry"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0962-8924(98)80017-2","article-title":"Trojan Peptides: The Penetratin System for Intracellular Delivery","volume":"8","author":"Derossi","year":"1998","journal-title":"Trends Cell Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3762\/bjnano.11.10","article-title":"Internalization Mechanisms of Cell-Penetrating Peptides","volume":"11","author":"Ruseska","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/acs.accounts.7b00204","article-title":"Jumping Hurdles: Peptides Able to Overcome Biological Barriers","volume":"50","author":"Giralt","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12031-012-9762-0","article-title":"PACAP Is an Endogenous Protective Factor\u2014Insights from PACAP-Deficient Mice","volume":"48","author":"Reglodi","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"C233","DOI":"10.1152\/ajpcell.00223.2017","article-title":"Src Family Kinase Inhibitors Blunt PACAP-Induced PAC1 Receptor Endocytosis, Phosphorylation of ERK, and the Increase in Cardiac Neuron Excitability","volume":"314","author":"Tompkins","year":"2018","journal-title":"Am. J. Physiol.\u2014Cell Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbamcr.2012.02.001","article-title":"Receptor-Independent Cellular Uptake of Pituitary Adenylate Cyclase-Activating Polypeptide","volume":"1823","author":"Doan","year":"2012","journal-title":"Biochim. Biophys. Acta BBA\u2014Mol. Cell Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bmcl.2016.11.083","article-title":"Intelligent Substance Delivery into Cells Using Cell-Penetrating Peptides","volume":"27","author":"Tashima","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Cesbron, Y., Shaheen, U., Free, P., and L\u00e9vy, R. (2015). TAT and HA2 Facilitate Cellular Uptake of Gold Nanoparticles but Do Not Lead to Cytosolic Localisation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0121683"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1039\/D0BM00809E","article-title":"Nanomaterial Based Drug Delivery Systems for the Treatment of Neurodegenerative Diseases","volume":"8","author":"Ahlawat","year":"2020","journal-title":"Biomater. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"107518","DOI":"10.1016\/j.cclet.2022.05.032","article-title":"Advances of Nanoparticles as Drug Delivery Systems for Disease Diagnosis and Treatment","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Maity, P.P., Kapat, K., Poddar, P., Bora, H., Das, C.K., Das, P., Ganguly, S., Das, N.C., Dhara, D., and Mandal, M. (2023). Capra Cartilage-Derived Peptide Delivery via Carbon Nano-Dots for Cartilage Regeneration. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1213932"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Ganguly, S., and Margel, S. (2021). Design of Magnetic Hydrogels for Hyperthermia and Drug Delivery. Polymers, 13.","DOI":"10.3390\/polym13234259"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.2147\/IJN.S215941","article-title":"Development and Screening of Brain-Targeted Lipid-Based Nanoparticles with Enhanced Cell Penetration and Gene Delivery Properties","volume":"14","author":"Lakkadwala","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.colsurfb.2017.10.062","article-title":"Solid Lipid Nanoparticles for Delivery of Andrographolide across the Blood-Brain Barrier: In Vitro and in Vivo Evaluation","volume":"161","author":"Graverini","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the Design of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Targeting Brain Diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured Lipid Carriers: Promising Drug Delivery Systems for Future Clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review Emphasizing on Particle Structure and Drug Release","volume":"133","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15171\/apb.2017.002","article-title":"Application of Various Types of Liposomes in Drug Delivery Systems","volume":"7","author":"Alavi","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.apsb.2021.02.013","article-title":"Recent Advances in Drug Delivery Applications of Cubosomes, Hexosomes, and Solid Lipid Nanoparticles","volume":"11","author":"Yaghmur","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2017.11.049","article-title":"Nanoemulsion as Pharmaceutical Carrier for Dermal and Transdermal Drug Delivery: Formulation Development, Stability Issues, Basic Considerations and Applications","volume":"270","author":"Rai","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: Concepts, Development and Applications in Drug Delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/anie.201804067","article-title":"Cubosomes: The Next Generation of Smart Lipid Nanoparticles?","volume":"58","author":"Barriga","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1248\/cpb.c19-00370","article-title":"Novel Cubosome System Resistant to Lipid Removal by Serum Albumin","volume":"67","author":"Uyama","year":"2019","journal-title":"Chem. Pharm. Bull."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Rakotoarisoa, M., Angelov, B., Espinoza, S., Khakurel, K., Bizien, T., and Angelova, A. (2019). Cubic Liquid Crystalline Nanostructures Involving Catalase and Curcumin: BioSAXS Study and Catalase Peroxidatic Function after Cubosomal Nanoparticle Treatment of Differentiated SH-SY5Y Cells. Molecules, 24.","DOI":"10.3390\/molecules24173058"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez Leo, E.E., and Segura Campos, M.R. (2020). Neuroprotective Effect from Salvia Hispanica Peptide Fractions on pro-Inflammatory Modulation of HMC3 Microglial Cells. J. Food Biochem., 44.","DOI":"10.1111\/jfbc.13207"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nbd.2016.01.021","article-title":"Biology of GDNF and Its Receptors\u2014Relevance for Disorders of the Central Nervous System","volume":"97","author":"Andressoo","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2006.01.083","article-title":"Application of a Blood\u2013Brain-Barrier-Penetrating Form of GDNF in a Mouse Model for Parkinson\u2019s Disease","volume":"1082","author":"Dietz","year":"2006","journal-title":"Brain Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"331","DOI":"10.14336\/AD.2015.0825","article-title":"The Involvement of BDNF, NGF and GDNF in Aging and Alzheimer\u2019s Disease","volume":"6","author":"Budni","year":"2015","journal-title":"Aging Dis."},{"key":"ref_158","first-page":"6879","article-title":"Enhanced Bioavailability of Nerve Growth Factor with Phytantriol Lipid-Based Crystalline Nanoparticles in Cochlea","volume":"10","author":"Bu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"120411","DOI":"10.1016\/j.ijpharm.2021.120411","article-title":"Cubosomes Enhance Drug Permeability across the Blood\u2013Brain Barrier in Zebrafish","volume":"600","author":"Azhari","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s42004-023-01043-9","article-title":"Sustained CREB Phosphorylation by Lipid-Peptide Liquid Crystalline Nanoassemblies","volume":"6","author":"Wu","year":"2023","journal-title":"Commun. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Mwema, A., Bottemanne, P., Paquot, A., Ucakar, B., Vanvarenberg, K., Alhouayek, M., Muccioli, G.G., and des Rieux, A. (2023). Lipid Nanocapsules for the Nose-to-Brain Delivery of the Anti-Inflammatory Bioactive Lipid PGD2-G. Nanomed. Nanotechnol. Biol. Med., 48.","DOI":"10.1016\/j.nano.2022.102633"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1007\/s12035-015-9372-2","article-title":"Gelatin Nanostructured Lipid Carriers Incorporating Nerve Growth Factor Inhibit Endoplasmic Reticulum Stress-Induced Apoptosis and Improve Recovery in Spinal Cord Injury","volume":"53","author":"Zhu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the Blood-Brain Barrier with Nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_164","first-page":"11","article-title":"Pathways for Small Molecule Delivery to the Central Nervous System across the Blood-Brain Barrier","volume":"6","author":"Mikitsh","year":"2014","journal-title":"Perspect. Med. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","article-title":"Overcoming Blood\u2013Brain Barrier Transport: Advances in Nanoparticle-Based Drug Delivery Strategies","volume":"37","author":"Ding","year":"2020","journal-title":"Mater. Today"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1039\/C7TB01314K","article-title":"Size- and Shape-Dependent Effects of Titanium Dioxide Nanoparticles on the Permeabilization of the Blood\u2013Brain Barrier","volume":"5","author":"Liu","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-Mediated Brain Drug Delivery: Overcoming Blood\u2013Brain Barrier to Treat Neurodegenerative Diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Shakeri, S., Ashrafizadeh, M., Zarrabi, A., Roghanian, R., Afshar, E.G., Pardakhty, A., Mohammadinejad, R., Kumar, A., and Thakur, V.K. (2020). Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics. Biomedicines, 8.","DOI":"10.3390\/biomedicines8010013"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1021\/nn501069c","article-title":"A Multifunctional Polymeric Nanotheranostic System Delivers Doxorubicin and Imaging Agents across the Blood\u2013Brain Barrier Targeting Brain Metastases of Breast Cancer","volume":"8","author":"Li","year":"2014","journal-title":"ACS Nano"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1038\/s41598-019-49028-w","article-title":"Fate of Nanoparticles in the Central Nervous System after Intrathecal Injection in Healthy Mice","volume":"9","author":"Householder","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/jcbfm.2014.220","article-title":"Systemically Administered Brain-Targeted Nanoparticles Transport Peptides across the Blood\u2014Brain Barrier and Provide Neuroprotection","volume":"35","author":"Yemisci","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.smaim.2022.03.001","article-title":"Liquid Crystalline Lipid Nanoparticles for Combined Delivery of Curcumin, Fish Oil and BDNF: In Vitro Neuroprotective Potential in a Cellular Model of Tunicamycin-Induced Endoplasmic Reticulum Stress","volume":"3","author":"Rakotoarisoa","year":"2022","journal-title":"Smart Mater. Med."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Dudhipala, N., and Gorre, T. (2020). Neuroprotective Effect of Ropinirole Lipid Nanoparticles Enriched Hydrogel for Parkinson\u2019s Disease: In Vitro, Ex Vivo, Pharmacokinetic and Pharmacodynamic Evaluation. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050448"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"105314","DOI":"10.1016\/j.ejps.2020.105314","article-title":"Quercetin Lipid Nanoparticles Functionalized with Transferrin for Alzheimer\u2019s Disease","volume":"148","author":"Pinheiro","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","article-title":"Solid Lipid Nanoparticles for Targeted Brain Drug Delivery","volume":"59","author":"Blasi","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41467-020-14906-9","article-title":"Melittin-Lipid Nanoparticles Target to Lymph Nodes and Elicit a Systemic Anti-Tumor Immune Response","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1515\/ntrev-2012-0040","article-title":"Immune Responses of Therapeutic Lipid Nanoparticles","volume":"2","author":"Chen","year":"2013","journal-title":"Nanotechnol. Rev."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of Nanoparticle Design for Overcoming Biological Barriers to Drug Delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Reglodi, D., and Tamas, A. (2016). Pituitary Adenylate Cyclase Activating Polypeptide\u2014PACAP, Springer International Publishing. Current Topics in Neurotoxicity.","DOI":"10.1007\/978-3-319-35135-3"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamaneurol.2014.3625","article-title":"Association of Pituitary Adenylate Cyclase\u2013Activating Polypeptide With Cognitive Decline in Mild Cognitive Impairment Due to Alzheimer Disease","volume":"72","author":"Han","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1096\/fj.10-180133","article-title":"Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Slows down Alzheimer\u2019s Disease-like Pathology in Amyloid Precursor Protein-Transgenic Mice","volume":"25","author":"Rat","year":"2011","journal-title":"FASEB J."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.regpep.2006.06.016","article-title":"Neuroprotection by Endogenous and Exogenous PACAP Following Stroke","volume":"137","author":"Chen","year":"2006","journal-title":"Regul. Pept."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0006-291X(05)80159-7","article-title":"Pituitary Adenylate Cyclase Activating Polypeptide Provokes Cultured Rat Chromaffin Cells to Secrete Adrenaline","volume":"182","author":"Watanabe","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Jungling, A., Reglodi, D., Maasz, G., Zrinyi, Z., Schmidt, J., Rivnyak, A., Horvath, G., Pirger, Z., and Tamas, A. (2021). Alterations of Nigral Dopamine Levels in Parkinson\u2019s Disease after Environmental Enrichment and PACAP Treatment in Aging Rats. Life, 11.","DOI":"10.3390\/life11010035"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1039\/C9FO00855A","article-title":"The Memory Improving Effects of Round Scad (Decapterus maruadsi) Hydrolysates on Sleep Deprivation-Induced Memory Deficits in Rats via Antioxidant and Neurotrophic Pathways","volume":"10","author":"Zhang","year":"2019","journal-title":"Food Funct."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1568026024607508","article-title":"Peptide Inhibitors of Beta Amyloid Aggregation","volume":"2","author":"Findeis","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnagi.2018.00021","article-title":"Use of Peptides for the Management of Alzheimer\u2019s Disease: Diagnosis and Inhibition","volume":"10","author":"Baig","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/IJN.S335774","article-title":"Examination of Effective Buccal Absorption of Salmon Calcitonin Using Cell-Penetrating Peptide-Conjugated Liposomal Drug Delivery System","volume":"17","author":"Keum","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/acs.molpharmaceut.2c00537","article-title":"Co-Administration of Transportan Peptide Enhances the Cellular Entry of Liposomes in the Bystander Manner Both In Vitro and In Vivo","volume":"19","author":"Li","year":"2022","journal-title":"Mol. Pharm."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acsnano.8b07961","article-title":"Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine","volume":"13","author":"Zhai","year":"2019","journal-title":"ACS Nano"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/aor.12350","article-title":"Real-Time Trafficking of PEGylated Liposomes in the Rodent Focal Brain Ischemia Analyzed by Positron Emission Tomography","volume":"38","author":"Fukuta","year":"2014","journal-title":"Artif. Organs"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/acsami.2c17631","article-title":"Tunable Surface Charge Enables the Electrostatic Adsorption-Controlled Release of Neuroprotective Peptides from a Hydrogel\u2013Nanoparticle Drug Delivery System","volume":"15","author":"Ho","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neures.2022.05.003","article-title":"Microbiota-Gut-Brain Axis in the Alzheimer\u2019s Disease Pathology\u2014An Overview","volume":"181","author":"Giridharan","year":"2022","journal-title":"Neurosci. Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"van der Alzheimer\u2019s Disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer\u2019s Disease Facts and Figures","volume":"15","author":"Association","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.foodchem.2013.06.089","article-title":"Novel Angiotensin I-Converting Enzyme Inhibitory Peptide Derived from Bovine Casein","volume":"141","author":"Yamada","year":"2013","journal-title":"Food Chem."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Min, L.-J., Kobayashi, Y., Mogi, M., Tsukuda, K., Yamada, A., Yamauchi, K., Abe, F., Iwanami, J., Xiao, J.-Z., and Horiuchi, M. (2017). Administration of Bovine Casein-Derived Peptide Prevents Cognitive Decline in Alzheimer Disease Model Mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171515"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-Based Vaccines: Current Progress and Future Challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Silva, S., Almeida, A.J., and Vale, N. (2019). Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review. Biomolecules, 9.","DOI":"10.3390\/biom9010022"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nano.2018.09.010","article-title":"Cationic Carrier Peptide Enhances Cerebrovascular Targeting of Nanoparticles in Alzheimer\u2019s Disease Brain","volume":"16","author":"Ahlschwede","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2174\/1389201019666180226152542","article-title":"A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer\u2019s Disease Treatment","volume":"18","author":"Zhang","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpb.2019.12.014","article-title":"Progress and Perspectives of Brain-Targeting Lipid-Based Nanosystems via the Nasal Route in Alzheimer\u2019s Disease","volume":"148","author":"Akel","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct Nose to Brain Drug Delivery via Integrated Nerve Pathways Bypassing the Blood\u2013Brain Barrier: An Excellent Platform for Brain Targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s13346-021-01086-2","article-title":"Using Nanotechnology to Deliver Biomolecules from Nose to Brain\u2014Peptides, Proteins, Monoclonal Antibodies and RNA","volume":"12","author":"Borrajo","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1208\/s12249-016-0552-9","article-title":"Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency","volume":"18","author":"Boche","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/npp.2014.61","article-title":"Intranasal Delivery of a Peptide with Antidepressant-Like Effect","volume":"39","author":"Brown","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"118635","DOI":"10.1016\/j.ijpharm.2019.118635","article-title":"Strategies to Facilitate or Block Nose-to-Brain Drug Delivery","volume":"570","author":"Martins","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2023.04.021","article-title":"Intranasal Nanotherapeutics for Brain Targeting and Clinical Studies in Parkinson\u2019s Disease","volume":"358","author":"Saha","year":"2023","journal-title":"J. Control. Release"}],"container-title":["Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4991\/13\/23\/3004\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:27:56Z","timestamp":1760131676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4991\/13\/23\/3004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":208,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["nano13233004"],"URL":"https:\/\/doi.org\/10.3390\/nano13233004","relation":{},"ISSN":["2079-4991"],"issn-type":[{"value":"2079-4991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]}}}